F. Franssen (Horn, Netherlands), L. Vanfleteren (Haelen, Netherlands)
Late Breaking Abstract - Right heart structural changes, exercise capacity and stress induced right ventricle dysfunction in non- severe COPD patients without pulmonary hypertension at rest.
R. Cherneva (sofia, Bulgaria), Z. Cherneva (sofia, Bulgaria), D. Valev (sofia, Bulgaria), R. Petkov (sofia, Bulgaria), D. Kostadinov (sofia, Bulgaria)
|  |
Comorbidities in chronic obstructive pulmonary disease: a nation-wide twin study
H. Meteran (Copenhagen, Denmark), S. Thomsen (Copenhagen, Denmark), M. Miller (Birmingham, United Kingdom), T. Sigsgaard (Aarhus, Denmark), V. Backer (Copenhagen, Denmark)
|   |
Association between centrilobular emphysema and coronary artery calcification: mediation analysis in the SPIROMICS cohort
S. Bhatt (Birmingham, United States of America), H. Nath (Birmingham, United States of America), Y. Kim (Birmingham, United States of America), R. Ramachandran (Birmingham, United States of America), J. Watts (Birmingham, United States of America), N. Terry (Birmingham, United States of America), S. Sonavane (Birmingham, United States of America), S. Deshmane (Birmingham, United States of America), P. Woodruff (San Francisco, United States of America), E. Oelsner (New York, United States of America), S. Bodduluri (Birmingham, United States of America), M. Han (Ann Arbor, United States of America), W. Labaki (Ann Arbor, United States of America), J. Wells (Birmingham, United States of America), F. Martinez (New York, United States of America), G. Barr (New York, United States of America), M. Dransfield (Birmingham, United States of America)
| |
In people at high risk of cardiovascular disease, co-existing COPD is not independently associated with macrovascular or microvascular disease
S. Ruickbie (London, United Kingdom), D. Burrage (London, United Kingdom), M. Bajaj (London, United Kingdom), C. Spilling (London, United Kingdom), J. Dodd (Bristol, United Kingdom), A. Prasad (London, United Kingdom), T. Barrick (London, United Kingdom), P. Jones (London, United Kingdom), E. Baker (London, United Kingdom)
| |
Influence of body mass on predicted values of static hyperinflation in COPD
P. Alter (Marburg, Germany), K. Rabe (Grosshansdorf, Germany), H. Schulz (Munich, Germany), C. Vogelmeier (Marburg, Germany), R. Jörres (Munich, Germany)
| |
Association between ICS therapy for COPD and diabetes onset and progression
J. Voorham (Singapore, Singapore), N. Roche (Paris, France), J. Stephens (Swansia, United Kingdom), H. Park (Seoul, Republic of Korea), R. Fogel (East Hanover, United States of America), A. Clemens (Basel, Switzerland), G. Brusselle (Ghent, Belgium), D. Price (Singapore, Singapore)
|  |
Low FFMI according to ESPEN cut-offs is a strong independent predictor of mortality in patients with COPD
I. Sarc (golnik, Slovenia), T. Kosten (golnik, Slovenia), T. Hafner (golnik, Slovenia), B. Zupanc (golnik, Slovenia), K. Ziherl (golnik, Slovenia)
| |
Score for the identification of osteoporosis in smokers (SIOS): its development using clinical, radiological and biochemical information
P. Rivera Ortega (Pamplona, Spain), J. González Gutiérrez (Pamplona, Spain), P. Restituto Aranguíbel (Pamplona, Spain), N. Varo Cenarruzabeitia (Pamplona, Spain), M. Colina Lorda (Pamplona, Spain), M. Calleja Canelas (Pamplona, Spain), M. Rodriguez Fraile (Pamplona, Spain), G. Bastarrika Alemán (Pamplona, Spain), A. Alcaide Ocaña (Pamplona, Spain), A. Campo Ezquibela (Pamplona, Spain), J. Zulueta Francés (Pamplona, Spain), J. Torres Tajes (Pamplona, Spain)
| |